Still the best of times
Article Abstract:
The above-average growth enjoyed by the US pharmaceutical industry in 1998 is expected to continue into the next century. Factors contributing to the projected industry growth include increasing life expectancies, aging baby boom generation, expected introduction of new breakthrough drugs and a more favorable regulatory environment. Several drug companies are also likely to continue to benefit from new consolidations and aggressive marketing strategies in the future.
Publication Name: Standard & Poor's Industry Surveys: Trends & Projections
Subject: Business, general
ISSN: 0196-4666
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Robust forward momentum continues
Article Abstract:
The total sales of the US pharmaceutical industry is expected to increase from the estimated $125 billion in 1998 to about $140 billion in 1999. Key demand factors driving the projected sales growth include strong demographic expansion in older generations, increasing life expectancies and planned introduction of several new breakthrough drugs. The US is also expected to remain the largest and fastest growing drug market in the world.
Publication Name: Standard & Poor's Industry Surveys: Trends & Projections
Subject: Business, general
ISSN: 0196-4666
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: DARWin: the evolution of data collection. Regulating drug prices: where do we go from here? The draining of a drug
- Abstracts: Maintaining quality standards in franchise chains. Consumer protection laws: violator detection and enforcement strategy
- Abstracts: Video dialtone: its potential for social change. Video dialtone network architecture. Tough year as cable operators wait it out